| Mrs Laura F Burch, AA-C | |
|
6780 Mayfield Rd, Mayfield Heights, OH 44124-2203 | |
| (440) 312-4500 | |
| Not Available |
| Full Name | Mrs Laura F Burch |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 16 Years |
| Location | 6780 Mayfield Rd, Mayfield Heights, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194985655 | NPI | - | NPPES |
| 67.000141 | Other | OH | OHIO LICENCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (Georgia) | Secondary |
| 367H00000X | Anesthesiologist Assistant | 67.000141 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hillcrest Hospital | Mayfield heights, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, according to a study in the December 16 issue of JAMA.
Anesthetics are effective in reducing the pain of circumcision in newborns, judging from the baby's heart rate and time spent crying after the procedure, a new analysis finds.
New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.
Nektar Therapeutics announced today that data presented at the European Society for Medical Oncology (ESMO) 12th World Congress on Gastrointestinal Cancer demonstrates that NKTR-102, the company's lead oncology compound, exhibits superior activity compared to irinotecan as part of either a monotherapy or combination regimen in tumor models of gastrointestinal cancers.
Roche, OrbiMed, and McKinsey announced fifteen finalists of the SEED Competition at the SEED Finalist Coaching Day event in Shanghai's Zhangjiang Hi-Tech Park on March 2, 2010. The event was managed and presented by ChinaBio® Accelerator. The finalists will go on to compete for the grand prize of RMB 300,000 to be presented at the SEED Final Competition and Award Ceremony in Shanghai on April 23, 2010.
› Verified 4 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, according to a study in the December 16 issue of JAMA.
Anesthetics are effective in reducing the pain of circumcision in newborns, judging from the baby's heart rate and time spent crying after the procedure, a new analysis finds.
New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.
Nektar Therapeutics announced today that data presented at the European Society for Medical Oncology (ESMO) 12th World Congress on Gastrointestinal Cancer demonstrates that NKTR-102, the company's lead oncology compound, exhibits superior activity compared to irinotecan as part of either a monotherapy or combination regimen in tumor models of gastrointestinal cancers.
Roche, OrbiMed, and McKinsey announced fifteen finalists of the SEED Competition at the SEED Finalist Coaching Day event in Shanghai's Zhangjiang Hi-Tech Park on March 2, 2010. The event was managed and presented by ChinaBio® Accelerator. The finalists will go on to compete for the grand prize of RMB 300,000 to be presented at the SEED Final Competition and Award Ceremony in Shanghai on April 23, 2010.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Laura F Burch, AA-C Cleveland Clinic 9500 Euclid Ave, Cleveland, OH 44195-0001 Ph: (800) 223-2273 | Mrs Laura F Burch, AA-C 6780 Mayfield Rd, Mayfield Heights, OH 44124-2203 Ph: (440) 312-4500 |
News Archive
Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, according to a study in the December 16 issue of JAMA.
Anesthetics are effective in reducing the pain of circumcision in newborns, judging from the baby's heart rate and time spent crying after the procedure, a new analysis finds.
New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.
Nektar Therapeutics announced today that data presented at the European Society for Medical Oncology (ESMO) 12th World Congress on Gastrointestinal Cancer demonstrates that NKTR-102, the company's lead oncology compound, exhibits superior activity compared to irinotecan as part of either a monotherapy or combination regimen in tumor models of gastrointestinal cancers.
Roche, OrbiMed, and McKinsey announced fifteen finalists of the SEED Competition at the SEED Finalist Coaching Day event in Shanghai's Zhangjiang Hi-Tech Park on March 2, 2010. The event was managed and presented by ChinaBio® Accelerator. The finalists will go on to compete for the grand prize of RMB 300,000 to be presented at the SEED Final Competition and Award Ceremony in Shanghai on April 23, 2010.
› Verified 4 days ago
Kevin Jackson, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 6780 Mayfield Rd, Mayfield Heights, OH 44124 Phone: 440-312-4500 | |
Uyen Minh Bui, AA-C Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 6780 Mayfield Rd, Mayfield Heights, OH 44124 Phone: 440-312-5181 |